filgrastim-txid 480 MCG in 0.8 ML Prefilled Syringe

RxCUI: 2700378
RxNorm name: filgrastim-txid 480 MCG in 0.8 ML Prefilled Syringe
Display name: filgrastim-txid 480 MCG in 0.8 ML Prefilled Syringe
Full name: filgrastim-txid 480 MCG in 0.8 ML Prefilled Syringe
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761126	Nypozi	filgrastim-txid	351(k) Biosimilar	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NYPOZI txid	FILGRASTIM-TXID	Tanvex BioPharma USA, Inc.	89092bb8-6a20-e23e-e053-2a95a90aa750	2026-01-15	Warnings, Adverse reactions	Exact identifier rxcui: 2700378
NYPOZI	FILGRASTIM-TXID	Cipla USA Inc.	575d164d-45fa-4e3e-81e4-2652d96673d1	2025-05-01	Warnings, Adverse reactions	Exact identifier rxcui: 2700378

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
89092bb8-6a20-e23e-e053-2a95a90aa750	filgrastim-txid 480 MCG in 0.8 ML Prefilled Syringe [PSN] · 0.8 ML filgrastim-txid 0.6 MG/ML Prefilled Syringe [SCD] · filgrastim-txid 480 MCG per 0.8 ML Prefilled Syringe [SY]	3	5	These highlights do not include all the information needed to use NYPOZI safely and effectively. See full prescribing information for NYPOZI. NYPOZI™ (filgrastim-txid) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 NYPOZI (filgrastim-txid) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differ	20260115
575d164d-45fa-4e3e-81e4-2652d96673d1	filgrastim-txid 480 MCG in 0.8 ML Prefilled Syringe [PSN] · 0.8 ML filgrastim-txid 0.6 MG/ML Prefilled Syringe [SCD] · filgrastim-txid 480 MCG per 0.8 ML Prefilled Syringe [SY]	3	1	These highlights do not include all the information needed to use NYPOZI safely and effectively. See full prescribing information for NYPOZI. NYPOZI (filgrastim-txid) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 NYPOZI (filgrastim-txid) is biosimilar1 to NEUPOGEN® (filgrastim). Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no c	20250501